Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Depakote
DRUG
3 trials
Sponsors
Weill Medical College of Cornell University
, Hearthstone Alzheimer Care
, Lawson, William B., M.D., PhD, DFAPA
Conditions
Bipolar Disorder
Dementia
Solid Tumor Malignancies
Phase 1
Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies
Terminated
NCT00195156
Weill Medical College of Cornell University
Solid Tumor Malignancies
Start: 2003-07-31
Updated: 2006-09-14
Study of Depakote for Behavioral and Psychological Symptoms in Dementia
NCT00197834
Hearthstone Alzheimer Care
Dementia
Start: 2004-03-31
Target: 20
Updated: 2006-08-15
Phase 4
Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder
Withdrawn
NCT01075126
Lawson, William B., M.D., PhD, DFAPA
Bipolar Disorder
Start: 2006-12-31
End: 2006-12-31
Target: 50
Updated: 2010-02-24
Related Papers
All‐<i>trans</i> retinoic acid (ATRA)‐induced <i>TFEB</i> expression is required for myeloid differentiation in acute promyelocytic leukemia (APL)
European Journal Of Haematology
2019-12-07
25 citations
ATRA-Induced Activation of the Autophagy Regulator Tfeb Regulates Myeloid Differentiation in Acute Promyelocytic Leukemia
Blood
2014-12-06